Logo image
Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma : Results of a randomized double-blind trial
Journal article   Peer reviewed

Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma : Results of a randomized double-blind trial

J. M Vose, A. N Pandite, J. M FERNANDEZ RANADA, P. J Stiff, I Tabbara, W Longo, E. A Copelan, C Nichols, A Smith, D. L Topolsky, …
Journal of clinical oncology, v 15(4), pp 1617-1623
1997
PMID: 9193361

Abstract

Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow, stem cells transplantation. Graft versus host reaction Medical sciences Transfusions. Complications. Transfusion reactions. Cell and gene therapy

Metrics

8 Record Views
17 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web of Science research areas
Oncology
Logo image